RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
West Nile Virus Global Clinical Trials Review, Q1, 2011
Apr 2011 - 24 pages - $1,000
Epidemiology: Hepatitis C - Hepatitis C virus will remain a prevalent bloodborne disease in the seven major markets, primarily transmitted through injection drug use
Feb 2011 - 26 pages - $5,700
Victrelis (boceprevir) - First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Approved in The US and Telaprevir to Follow
May 2011 - 6 pages - $500
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 32 pages - $250
Forecast Insight: HIV – Increasing dominance of fixed dose combinations raises bar for single agents
Jun 2010 - 126 pages - $15,200
West Nile Virus Infections - Pipeline Review, Q2 2011
May 2011 - 34 pages - $500
West Nile Virus Infections - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Respiratory Syncytial Virus (RSV) Infection Global Clinical Trials Review, Q4, 2010
Dec 2010 - 48 pages - $1,000
Herpes Simplex Virus Infection Therapy Area Pipeline Report
Nov 2010 - 245 pages - $1,495
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report
Nov 2010 - 160 pages - $1,495
More Related Market Research Reports >>>

Your selection

Therapeutic target
Infectious diseases del
Bacteria or virus del
Human papilloma virus del
Year
2001 del

Browse By

Industry sector
Academic/Research
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Non-profit org./Government
Pharmaceutical
Research tools
Service

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us